Consider Suggesting Pioglitazone for Patients with Prediabetes and Prior Stroke

You'll hear debate about using pioglitazone (Actos, etc) to decrease CV risk after an ischemic patients WITHOUT diabetes.

New evidence suggests pioglitazone may improve CV outcomes in patients with a prior stroke or TIA and insulin resistance or PREdiabetes.

Using pioglitazone for about 5 years prevents a second stroke or heart attack in 1 in 36 of these patients, and slows progression to diabetes in 1 in 26...but does not decrease overall mortality.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote